[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371216-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371216-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nos3-gene-polymorphisms-rs2070744-and-rs1799983-and-differentiated-thyroid-cancer-investigating-associations-with-clinical-outcomes","NOS3 Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer - Investigating Associations with Clinical Outcomes","","Differentiated thyroid cancer (DTC) is the most common endocrine malignancy, and genetic variation may affect its development, course, and prognosis. This case-control study evaluated nitric oxide synthase 3 (NOS3) gene polymorphisms (−786T>C/rs2070744 and Glu298Asp/rs1799983) as potential prognostic biomarkers by analyzing clinical characteristics and outcomes. Among 172 participants (88 DTC patients and 84 matched controls), genotyping used TaqMan assays and comparisons employed chi-square testing. No significant differences were observed between patients and controls, and neither polymorphism showed meaningful associations with biochemical control, structural control, or loco-regional metastases, indicating limited biomarker utility.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nos3-gene-polymorphisms-rs2070744-and-rs1799983-and-differentiated-thyroid-cancer-investigating-associations-with-clinical-outcomes/371216/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nos3-gene-polymorphisms-rs2070744-and-rs1799983-and-differentiated-thyroid-cancer-investigating-associations-with-clinical-outcomes/371216.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this NOS3 study in differentiated thyroid cancer?","Question",{"text":63,"@type":64},"To assess whether NOS3 gene polymorphisms (rs2070744 and rs1799983) are associated with clinical characteristics and outcomes of differentiated thyroid cancer, and whether they could serve as prognostic biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants and comparison groups defined?",{"text":68,"@type":64},"A case-control design enrolled 172 individuals, including 88 patients with differentiated thyroid cancer and 84 healthy controls matched for age and sex.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the study’s key findings regarding rs2070744 and rs1799983?",{"text":72,"@type":64},"The distributions of rs2070744 and rs1799983 showed no significant differences between DTC patients and healthy controls, and no significant associations were found with biochemical control, structural control, or loco-regional metastases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371216,1790395119,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nNOS3 Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer: Investigating Associations with Clinical Outcomes  \nRobert Aurelian Tiucă 1,2,3, Raluca Monica Pop 2,3, *, Oana Mirela Tiucă 4,5, Claudia Bănescu 6,7,8, Ana Claudia Cârstea 7, Cristina Preda 9,10 and Ionela Maria Pas, canu 2,3  \nAcademic Editor: Alfonso Baldi  \nReceived: 11 December 2024  \nRevised: 12 January 2025  \nAccepted: 16 January 2025  \nPublished: 17 January 2025  \nCitation: Tiucă, R.A.; Pop, R.M.; Tiucă, O.M.; Bănescu, C.; Cârstea, A.C.; Preda, C.; Pas, canu, I.M. NOS3 Gene Polymorphisms (rs2070744 andrs1799983) and Differentiated Thyroid Cancer: Investigating Associations with Clinical Outcomes. Int. J. Mol. Sci. 2025, 26, 759. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26020759](10.3390/ijms26020759)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania  \n2 Department of Endocrinology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania  \n3 Compartment of Endocrinology, Mures County Clinical Hospital, 540139 Targu Mures, Romania  \n4 Department of Dermatology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania  \n5 Dermatology Clinic, Mures County Clinical Hospital, 540015 Targu Mures, Romania  \n6 Department of Medical Genetics, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania  \n7 Center for Advanced Medical and Pharmaceutical Research, Genetics Laboratory, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania  \n8 Medical Genetics Laboratory, Emergency County Hospital of Targu Mures, 540136 Targu Mures, Romania  \n9 Department of Endocrinology, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania  \n10 Department of Endocrinology,‘Sf. Spiridon’ County Hospital, 700111 Iasi, Romania  \n* Correspondence: [raluca.pop@umfst.ro](raluca.pop@umfst.ro)  \nAbstract: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy, with genetic factors playing an important role in its development and progression. This study investigated the association between nitric oxide synthase 3 (NOS3) gene polymorphisms (−786T>C or rs2070744 and Glu298Asp or c.894T>G or rs1799983) and the clinical characteristics and outcomes of DTC, aiming to evaluate their potential as biomarkers for prognosis. A case-control study was conducted, enrolling 172 individuals from the Endocrinology Clinics of Târgu Mures, and Ias, i, Romania, between 2021 and 2023 . This study included 88 patients with DTC and 84 healthy controls, matched for age and sex. DNA was extracted from blood samples, and the NOS3 polymorphisms were genotyped using TaqMan assays. Statistical analysis included chi-square tests with a significance level set at p \u003C 0.05 . The distribution of the rs2070744 and rs1799983 polymorphisms showed no significant differences between the patients with DTC and healthy controls (p = 0.387 and p = 0.329, respectively) . Furthermore, no significant associations were found between these polymorphisms and key clinical outcomes such as biochemical control, structural control, or loco-regional metastases. Our findings indicate that NOS3 rs2070744 and rs1799983 gene polymorphisms do not significantly influence the clinical outcomes of DTC, suggesting their limited utility as biomarkers for ","cbCairPpsgopEUp6","https://ap.wps.com/l/cbCairPpsgopEUp6","pdf",449915,15,"English","# Abstract\n# Introduction\n## Differentiated thyroid cancer overview\n## Genetic research and study rationale","[{\"question\":\"What was the main goal of this NOS3 study in differentiated thyroid cancer?\",\"answer\":\"To assess whether NOS3 gene polymorphisms (rs2070744 and rs1799983) are associated with clinical characteristics and outcomes of differentiated thyroid cancer, and whether they could serve as prognostic biomarkers.\"},{\"question\":\"How were participants and comparison groups defined?\",\"answer\":\"A case-control design enrolled 172 individuals, including 88 patients with differentiated thyroid cancer and 84 healthy controls matched for age and sex.\"},{\"question\":\"What were the study’s key findings regarding rs2070744 and rs1799983?\",\"answer\":\"The distributions of rs2070744 and rs1799983 showed no significant differences between DTC patients and healthy controls, and no significant associations were found with biochemical control, structural control, or loco-regional metastases.\"}]","NOS3 Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer - Investigating Associations with Clinical Outcomes | PDF",1790191541,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c01cc2d9e59578414ec65864142dc0d0.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2908d0fa718e8b3469084674a17a53f1.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f5757264e0609e38a9905728d97df1e.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14b34f8e143970ce1ff7501d9c2177ee.webp",980,1385]